{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:38:38Z","timestamp":1784299118643,"version":"3.55.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007623","name":"Emory University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007623","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1U54AG062334-01"],"award-info":[{"award-number":["1U54AG062334-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01HL157311"],"award-info":[{"award-number":["1R01HL157311"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.mcna.2023.12.006","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T04:39:30Z","timestamp":1705811970000},"page":"455-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optimal Medical Therapy for Stable Ischemic Heart Disease"],"prefix":"10.1016","volume":"108","author":[{"given":"Brett M.","family":"Montelaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rand","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Thames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja K.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.mcna.2023.12.006_bib1","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart Disease and Stroke Statistics-2023\u00a0Update: A Report From the American Heart Association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"11 Suppl","key":"10.1016\/j.mcna.2023.12.006_bib2","first-page":"S358","article-title":"Cost of illness of chronic angina","volume":"10","author":"Javitz","year":"2004","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.mcna.2023.12.006_bib3","series-title":"GBD compare","year":"2020"},{"key":"10.1016\/j.mcna.2023.12.006_bib4","series-title":"Braunwald: heart disease: a textbook of cardiovascular medicine","first-page":"1087","article-title":"Coronary Blood Flow and Myocardial Ischemia","author":"Ganz","year":"2001"},{"issue":"1","key":"10.1016\/j.mcna.2023.12.006_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1573402114666180918102735","article-title":"Three Generations of beta-blockers: History, Class Differences and Clinical Applicability","volume":"15","author":"do Vale","year":"2019","journal-title":"Curr Hypertens Rev"},{"issue":"9994","key":"10.1016\/j.mcna.2023.12.006_bib6","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(15)61283-1","article-title":"Pharmacological and emerging therapies in the treatment of chronic angina","volume":"386","author":"Husted","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2023.12.006_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jacc.2004.10.019","article-title":"Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: a serial transthoracic Doppler echocardiographic study","volume":"45","author":"Sugioka","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2023.12.006_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/08037050903450492","article-title":"Effect of carvedilol on coronary flow reserve in patients with hypertensive left-ventricular hypertrophy","volume":"19","author":"Xiaozhen","year":"2010","journal-title":"Blood Press"},{"issue":"2","key":"10.1016\/j.mcna.2023.12.006_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10557-006-0494-7","article-title":"Does the beta-blocker nebivolol increase coronary flow reserve?","volume":"21","author":"Togni","year":"2007","journal-title":"Cardiovasc Drugs Ther"},{"issue":"21","key":"10.1016\/j.mcna.2023.12.006_bib10","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000066912.58385.DE","article-title":"Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action","volume":"107","author":"Kalinowski","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/MCA.0b013e32830936bb","article-title":"The effect of nebivolol treatment on oxidative stress and antioxidant status in patients with cardiac syndrome-X","volume":"20","author":"Erdamar","year":"2009","journal-title":"Coron Artery Dis"},{"issue":"18","key":"10.1016\/j.mcna.2023.12.006_bib12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/eurheartj\/ehy811","article-title":"beta-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study","volume":"40","author":"Sorbets","year":"2019","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.mcna.2023.12.006_bib13","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jacc.2014.04.042","article-title":"beta-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease","volume":"64","author":"Andersson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.mcna.2023.12.006_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/2047487314533217","article-title":"Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis","volume":"22","author":"Belsey","year":"2015","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"10.1016\/j.mcna.2023.12.006_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10557-011-6327-3","article-title":"Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina","volume":"25","author":"Amosova","year":"2011","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"10.1016\/j.mcna.2023.12.006_bib18","article-title":"Neuropsychiatric Consequences of Lipophilic Beta-Blockers","volume":"57","author":"Cojocariu","year":"2021","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"16","key":"10.1016\/j.mcna.2023.12.006_bib19","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/CIRCULATIONAHA.111.037283","article-title":"Mechanisms of coronary artery spasm","volume":"124","author":"Lanza","year":"2011","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.mcna.2023.12.006_bib20","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1001\/jama.281.20.1927","article-title":"Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina","volume":"281","author":"Heidenreich","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2023.12.006_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/eurheartj\/ehy504","article-title":"Anti-anginal drugs-beliefs and evidence: systematic review covering 50 years of medical treatment","volume":"40","author":"Ferrari","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib22","first-page":"293","article-title":"Chronic Stable Angina","volume":"375","author":"Ohman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2023.12.006_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.RES.0000184694.03262.6d","article-title":"Explaining the phenomenon of nitrate tolerance","volume":"97","author":"Munzel","year":"2005","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib24","doi-asserted-by":"crossref","first-page":"e003196","DOI":"10.1161\/JAHA.116.003196","article-title":"Ranolazine: A Contemporary Review","volume":"5","author":"Rayner-Hartley","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9744","key":"10.1016\/j.mcna.2023.12.006_bib25","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mcna.2023.12.006_bib26","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10557-020-07124-4","article-title":"Ivabradine in Cardiovascular Disease Management Revisited: a Review","volume":"35","author":"Chen","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"10.1016\/j.mcna.2023.12.006_bib27","first-page":"810","article-title":"Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor","volume":"40","author":"Tse","year":"2015","journal-title":"P\u00a0T"},{"issue":"2","key":"10.1016\/j.mcna.2023.12.006_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: A 'diamond' approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2023.12.006_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000487936","article-title":"Treatment of Angina: Where Are We?","volume":"140","author":"Balla","year":"2018","journal-title":"Cardiology"},{"issue":"38","key":"10.1016\/j.mcna.2023.12.006_bib30","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.mcna.2023.12.006_bib31","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A\u00a0randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Group","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.mcna.2023.12.006_bib32","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.mcna.2023.12.006_bib33","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2023.12.006_bib34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/clc.23592","article-title":"Invasive therapy versus conservative therapy for patients with stable coronary artery disease: An updated meta-analysis","volume":"44","author":"Vij","year":"2021","journal-title":"Clin Cardiol"},{"issue":"29","key":"10.1016\/j.mcna.2023.12.006_bib35","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehy857","article-title":"Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization","volume":"40","author":"Crea","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2023.12.006_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.11.009","article-title":"Ischemia and no obstructive coronary arteries (INOCA): A narrative review","volume":"363","author":"Mehta","year":"2022","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.mcna.2023.12.006_bib37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4244\/EIJ-D-20-00779","article-title":"Invasive assessment of myocardial bridging in patients with angina and no obstructive coronary artery disease","volume":"16","author":"Pargaonkar","year":"2021","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.mcna.2023.12.006_bib38","doi-asserted-by":"crossref","first-page":"e011062","DOI":"10.1161\/CIRCINTERVENTIONS.121.011062","article-title":"Impact of Diastolic Vessel Restriction on Quality of Life in Symptomatic Myocardial Bridging Patients Treated With Surgical Unroofing: Preoperative Assessments With Intravascular Ultrasound and Coronary Computed Tomography Angiography","volume":"14","author":"Hashikata","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.mcna.2023.12.006_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jcin.2012.01.023","article-title":"Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study","volume":"5","author":"Wei","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0735-1097(90)90347-R","article-title":"Increased myocardial perfusion at rest and diminished perfusion reserve in patients with angina and angiographically normal coronary arteries","volume":"16","author":"Geltman","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mcna.2023.12.006_bib41","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4065\/73.12.1133","article-title":"Prevalence of coronary blood flow reserve abnormalities among patients with nonobstructive coronary artery disease and chest pain","volume":"73","author":"Hasdai","year":"1998","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib42","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(00)01163-3","article-title":"History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study","volume":"37","author":"Rutledge","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mcna.2023.12.006_bib43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.CIR.0000115525.92645.16","article-title":"Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)","volume":"109","author":"von Mering","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mcna.2023.12.006_bib44","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/cvr\/cvaa006","article-title":"Treatment of coronary microvascular dysfunction","volume":"116","author":"Bairey Merz","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mcna.2023.12.006_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2021.12.013","article-title":"Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease","volume":"348","author":"Mehta","year":"2022","journal-title":"Int J Cardiol"},{"issue":"7","key":"10.1016\/j.mcna.2023.12.006_bib46","first-page":"1577","article-title":"Cardiovascular Imaging Techniques to","volume":"13","author":"Mathew","year":"2020","journal-title":"Assess Microvascular Dysfunction"},{"key":"10.1016\/j.mcna.2023.12.006_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","article-title":"Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial","volume":"237","author":"Handberg","year":"2021","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.mcna.2023.12.006_bib48","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/heartjnl-2012-303305","article-title":"Effects of coronary sinus occlusion on myocardial ischaemia in humans: role of coronary collateral function","volume":"99","author":"Stoller","year":"2013","journal-title":"Heart"},{"issue":"6","key":"10.1016\/j.mcna.2023.12.006_bib49","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.mcna.2023.12.006_bib50","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamacardio.2023.2566","article-title":"Coronary Venous Pressure and Microvascular Hemodynamics in Patients With Microvascular Angina: A Randomized Clinical Trial","volume":"8","author":"Ullrich","year":"2023","journal-title":"JAMA Cardiology"},{"issue":"3","key":"10.1016\/j.mcna.2023.12.006_bib51","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/hrt.68.9.282","article-title":"Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms","volume":"68","author":"Lagerqvist","year":"1992","journal-title":"Br Heart J"},{"issue":"5","key":"10.1016\/j.mcna.2023.12.006_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/hrt.75.5.436","article-title":"Pain perception and brain evoked potentials in patients with angina despite normal coronary angiograms","volume":"75","author":"Frobert","year":"1996","journal-title":"Heart"},{"issue":"20","key":"10.1016\/j.mcna.2023.12.006_bib53","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJM199405193302003","article-title":"Imipramine in patients with chest pain despite normal coronary angiograms","volume":"330","author":"Cannon","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2023.12.006_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2019.08.055","article-title":"Refractory Angina: From Pathophysiology to New Therapeutic Nonpharmacological Technologies","volume":"13","author":"Gallone","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.mcna.2023.12.006_bib55","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0735-1097(90)90377-2","article-title":"Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries","volume":"16","author":"Cannon","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523001943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712523001943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T14:55:18Z","timestamp":1729090518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712523001943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0025712523001943"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2023.12.006","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Medical Therapy for Stable Ischemic Heart Disease","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}